Follow us

Open Orphan (ORPH)

Open Orphan (ORPH) ShareSoc presentation 11th May 2020

12 May 2020

Open Orphan Executive Chairman Cathal Friel presents an update at the ShareSoc Growth Company webinar 11th May 2020.

Introduction from Mike Dennis, ShareSoc – 00:23

Cathal Friel, Executive Chairman, Open Orphan.
Introduction – 00:55
About Open Orphan – 01:33
Management team – 08:39
Complementary Services Business – 10:26
World’s first Coronavirus challenge model – 11:28
About hVIVO – 14:19
Vaccine and Pharmaceutical product portfolio – 15:39
Genomic data capturing – 17:06
Contracts – 17:53
Open Orphan strategy – 18:07
hVIVO strategy – 18:17
Combined pipeline – 18:20
Revenue synergies – 19:42
Revenue growth and profitability – 21:30
Q&A – 23:25

Open Orphan PLC is a European-focussed, rare and orphan drug consulting services platform. The company consists of four elements: a European clinical research organisation and consultancy; an orphan drug services business; a Virtual Rep and Data Access Platform consisting of physicians and key opinion leaders; and a Health Data Platform to partner with Patient Advocacy Groups. The company is targeting rapid growth in one of the fastest growing sectors in the global pharmaceutical industry targeting under-supplied treatment for life threatening or very serious diseases and rare disorders.Venn Life Sciences Holdings PLC is engaged into a Clinical Research Organisation (CRO) providing a suite of consulting and clinical trial services to pharmaceutical, biotechnology, and medical device organizations.


Listen on the go


PIWORLD provides investors with the latest news and insight about listed companies and their management through either live or recorded investor presentations, management interviews, Capital Market Days and corporate overviews, together with interviews with leading fund managers or esteemed private investors in the small cap world.

Our Services

PIWORLD delivers high quality audio and video content to present anything from full-year & interim results to Capital Markets Days and corporate overviews. We bridge the gap between listed companies and the private investor community, who drive the share price and provide liquidity, providing a time and cost effective medium to reach this diverse and important audience.